twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2022
vol. 124
 
Share:
Share:
abstract:
Review paper

Inherited retinal dystrophies caused by RPE65 gene mutation: clinical presentation, economic and social burden

Katarzyna Jaśkowiak
1
,
Marcin Stopa
2
,
Maciej Krawczyński
3
,
Maciej Niewada
1, 4
,
Dominik Golicki
1, 4

  1. HealthQuest Spółka Komandytowa Sp. z o.o.
  2. Department of Ophthalmology, Chair of Ophthalmology and Optometry, Heliodor Swiecicki University Hospital, Poznan University of Medical Sciences, Poznan, Poland
  3. Chair and Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland
  4. Chair and Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Poland
KLINIKA OCZNA 2022, 124, 1: 7–15
Online publish date: 2021/12/08
View full text Get citation
 
PlumX metrics:
Inherited retinal dystrophies are a heterogeneous group of genetically determined disorders. The present paper discusses the role of mutation in the gene encoding the retinal pigment epithelium-specific protein RPE65 in the pathogenesis and course of dystrophies. Available epidemio-logical data are discussed with a focus on the clinical entities in which the RPE65 mutation is most typically identified, i.e. retinitis pigmentosa and Leber congenital amaurosis. As demonstrated by multiple studies, the lack of active retinal pigment epithelium-specific protein leads to near-total vision loss already in childhood or early adolescence.

The paper addresses the issue of economic burdens associated with visual disturbances or vision loss resulting from progressive visual dysfunc-tion, including the burden on the healthcare system and public payer, and relating to the loss of productivity (indirect costs). In addition, an attempt has been made to evaluate the latter in the Polish reality. Unquantifiable costs, understood as referring to the loss of quality of life caused by progressive visual dysfunction, are discussed from the perspective of both patients and their caregivers.
keywords:

inherited retinal dystrophies, RPE65, disease costs, direct costs, indirect costs, quality of life

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.